Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer - Schweizer, Michael T.; Gulati, Roman; Yezefski, Todd; Cheng, Heather H.; Mostaghel, Elahe; Haffner, Michael C.; Patel, Radhika A.; De Sarkar, Navonil; Ha, Gavin; Dumpit, Ruth; Woo, Brianna; Lin, Aaron; et al. (Prostate cancer and prostatic diseases, 2023)
Keywords: 631/67/1059; 631/67/589/466; Androgen Antagonists - therapeutic use; Androgens; Androgens - therapeutic use; Biomedical and Life Sciences; Biomedicine; Cancer Research; Castration; Chemotherapy; Clinical outcomes; Clinical trials; Deprivation; DNA damage; Endocrine therapy; Homologous recombination; Homologous recombination repair; Humans; Male; Metastases; Metastasis; Mutation; Nitriles - therapeutic use; Prostate cancer; Prostate-Specific Antigen - therapeutic use; Prostatic Neoplasms, Castration-Resistant - drug therapy; Prostatic Neoplasms, Castration-Resistant - genetics; Prostatic Neoplasms, Castration-Resistant - pathology; Reproductive Medicine; Testosterone; Treatment Outcome